Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 May;79(5):1401–1411. doi: 10.1172/JCI112968

Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern.

H M Lokhorst, S E Boom, B J Bast, P J Peters, T F Tedder, J Gerdes, E Petersen, R E Ballieux
PMCID: PMC424404  PMID: 3553239

Abstract

We examined bone marrow from myeloma patients for the presence of cells with the characteristics of the clonogenic cell in the myeloma stem cell assay. We identified a novel type of cell that contained cytoplasmic immunoglobulin of the relevant idiotype located in a cytoplasmic spot. This "spotted" Ig could be located in the rough endoplasmic reticulum. Spotted cells are highly proliferative, as evidenced by the nuclear staining with the antibody Ki67, and were found in the bone marrow from most of the myeloma patients studied. This type of cell was also present in patients with immunocytomas, in some cases of benign monoclonal gammopathy, and in patients in the state of polyclonal hypergammaglobulinemia. IgG subclass distribution of so-called spotted cells and plasma cells, found in a patient with pseudo biclonal gammopathy, indicates that spotted cells are intermediate between B cells and plasma cells. Spotted cells express the B cell-associated antigens HB4 and HB6 but do not express other B cluster of differentiation antigens or plasmacytoid antigens tested.

Full text

PDF
1401

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Anderson K. C., Bates M. P., Slaughenhoupt B., Schlossman S. F., Nadler L. M. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol. 1984 Jun;132(6):3172–3179. [PubMed] [Google Scholar]
  3. Anderson K. C., Park E. K., Bates M. P., Leonard R. C., Hardy R., Schlossman S. F., Nadler L. M. Antigens on human plasma cells identified by monoclonal antibodies. J Immunol. 1983 Mar;130(3):1132–1138. [PubMed] [Google Scholar]
  4. Bast B. J., Boom S. E., Ballieux R. E. Characterization of the colony-forming cell in monoclonal gammopathies. Blood. 1982 Sep;60(3):608–612. [PubMed] [Google Scholar]
  5. Bast E. J., Slaper-Cortenbach C. M., Verdonck L. F., Samson W., Ballieux R. E. Transient expression of a second monoclonal component in two forms of biclonal gammopathy. Br J Haematol. 1985 May;60(1):91–97. doi: 10.1111/j.1365-2141.1985.tb07389.x. [DOI] [PubMed] [Google Scholar]
  6. Bast E. J., van Camp B., Reynaert P., Wiringa G., Ballieux R. E. Idiotypic peripheral blood lymphocytes in monoclonal gammopathy. Clin Exp Immunol. 1982 Mar;47(3):677–682. [PMC free article] [PubMed] [Google Scholar]
  7. Bloem A. C., Bast E. J., Gmelig Meyling F. H., DeGast G. C., Ballieux R. E. Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: relationship between stimulation and surface phenotype. Clin Exp Immunol. 1982 Nov;50(2):355–359. [PMC free article] [PubMed] [Google Scholar]
  8. Breard J., Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol. 1980 Apr;124(4):1943–1948. [PubMed] [Google Scholar]
  9. Brooks D. A., Beckman I. G., Bradley J., McNamara P. J., Thomas M. E., Zola H. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. J Immunol. 1981 Apr;126(4):1373–1377. [PubMed] [Google Scholar]
  10. Caligaris-Cappio F., Bergui L., Tesio L., Pizzolo G., Malavasi F., Chilosi M., Campana D., van Camp B., Janossy G. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest. 1985 Sep;76(3):1243–1251. doi: 10.1172/JCI112080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Durie B. G., Young L. A., Salmon S. E. Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration. Blood. 1983 May;61(5):929–934. [PubMed] [Google Scholar]
  12. Edwards P. A. Monoclonal antibodies that bind to the human erythrocyte-membrane glycoproteins glycophorin A and Band 3 [proceedings]. Biochem Soc Trans. 1980 Jun;8(3):334–335. doi: 10.1042/bst0080334. [DOI] [PubMed] [Google Scholar]
  13. Fleit H. B., Wright S. D., Unkeless J. C. Human neutrophil Fc gamma receptor distribution and structure. Proc Natl Acad Sci U S A. 1982 May;79(10):3275–3279. doi: 10.1073/pnas.79.10.3275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Forster H. K., Gudat F. G., Girard M. F., Albrecht R., Schmidt J., Ludwig C., Obrecht J. P. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes. Cancer Res. 1982 May;42(5):1927–1934. [PubMed] [Google Scholar]
  15. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983 Jan 15;31(1):13–20. doi: 10.1002/ijc.2910310104. [DOI] [PubMed] [Google Scholar]
  16. Gerdes J., Schwarting R., Stein H. High proliferative activity of Reed Sternberg associated antigen Ki-1 positive cells in normal lymphoid tissue. J Clin Pathol. 1986 Sep;39(9):993–997. doi: 10.1136/jcp.39.9.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gesche A. H., Ashman L. K. Variations in antigen expression during the cell cycle of a human B-lymphoblastoid cell line. Leuk Res. 1985;9(1):147–156. doi: 10.1016/0145-2126(85)90028-1. [DOI] [PubMed] [Google Scholar]
  18. Geuze H. J., Slot J. W., van der Ley P. A., Scheffer R. C. Use of colloidal gold particles in double-labeling immunoelectron microscopy of ultrathin frozen tissue sections. J Cell Biol. 1981 Jun;89(3):653–665. doi: 10.1083/jcb.89.3.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Halper J. P., Knowles D. M., 2nd, Wang C. Y. Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers. Blood. 1980 Mar;55(3):373–382. [PubMed] [Google Scholar]
  20. Hamburger A., Salmon S. E. Primary bioassay of human myeloma stem cells. J Clin Invest. 1977 Oct;60(4):846–854. doi: 10.1172/JCI108839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hofmann V., Salmon S. E., Durie B. G. Drug resistance in multiple myeloma associated with high in vitro incorporation of 3H-thymidine. Blood. 1981 Sep;58(3):471–476. [PubMed] [Google Scholar]
  22. Janossy G., Prentice H. G. T cell subpopulations, monoclonal antibodies and their therapeutic applications. Clin Haematol. 1982 Oct;11(3):631–660. [PubMed] [Google Scholar]
  23. King M. A., Vivianwells J. Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity. Clin Exp Immunol. 1981 Sep;45(3):544–551. [PMC free article] [PubMed] [Google Scholar]
  24. Kubagawa H., Vogler L. B., Capra J. D., Conrad M. E., Lawton A. R., Cooper M. D. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med. 1979 Oct 1;150(4):792–807. doi: 10.1084/jem.150.4.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. LeBien T., Kersey J., Nakazawa S., Minato K., Minowada J. Analysis of human leukemia/lymphoma cell lines with monoclonal antibodies BA-1, BA-2 and BA-3. Leuk Res. 1982;6(3):299–305. doi: 10.1016/0145-2126(82)90091-1. [DOI] [PubMed] [Google Scholar]
  26. Lokhorst H. M., Boom S. E., Bast B. J., Ballieux R. E. Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique. Br J Haematol. 1986 Oct;64(2):271–275. doi: 10.1111/j.1365-2141.1986.tb04119.x. [DOI] [PubMed] [Google Scholar]
  27. Majdic O., Liszka K., Lutz D., Knapp W. Myeloid differentiation antigen defined by a monoclonal antibody. Blood. 1981 Dec;58(6):1127–1133. [PubMed] [Google Scholar]
  28. Martin P. J., Hansen J. A., Siadak A. W., Nowinski R. C. Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study. J Immunol. 1981 Nov;127(5):1920–1923. [PubMed] [Google Scholar]
  29. Mellstedt H., Hammarström S., Holm G. Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol. 1974 Jul;17(3):371–384. [PMC free article] [PubMed] [Google Scholar]
  30. Nadler L. M., Anderson K. C., Marti G., Bates M., Park E., Daley J. F., Schlossman S. F. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol. 1983 Jul;131(1):244–250. [PubMed] [Google Scholar]
  31. Nadler L. M., Stashenko P., Hardy R., van Agthoven A., Terhorst C., Schlossman S. F. Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol. 1981 May;126(5):1941–1947. [PubMed] [Google Scholar]
  32. Roth J., Lentze M. J., Berger E. G. Immunocytochemical demonstration of ecto-galactosyltransferase in absorptive intestinal cells. J Cell Biol. 1985 Jan;100(1):118–125. doi: 10.1083/jcb.100.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Slot J. W., Geuze H. J. A new method of preparing gold probes for multiple-labeling cytochemistry. Eur J Cell Biol. 1985 Jul;38(1):87–93. [PubMed] [Google Scholar]
  34. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3848–3852. doi: 10.1073/pnas.78.6.3848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Strous G. J., Berger E. G. Biosynthesis, intracellular transport, and release of the Golgi enzyme galactosyltransferase (lactose synthetase A protein) in HeLa cells. J Biol Chem. 1982 Jul 10;257(13):7623–7628. [PubMed] [Google Scholar]
  36. Tedder T. F., Clement L. T., Cooper M. D. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody. J Immunol. 1985 Mar;134(3):1539–1544. [PubMed] [Google Scholar]
  37. Tedder T. F., Clement L. T., Cooper M. D. Discontinuous expression of a membrane antigen (HB-7) during B lymphocyte differentiation. Tissue Antigens. 1984 Sep;24(3):140–149. doi: 10.1111/j.1399-0039.1984.tb02118.x. [DOI] [PubMed] [Google Scholar]
  38. Tokuyasu K. T., Singer S. J. Improved procedures for immunoferritin labeling of ultrathin frozen sections. J Cell Biol. 1976 Dec;71(3):894–906. doi: 10.1083/jcb.71.3.894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Trowbridge I. S., Omary M. B. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A. 1981 May;78(5):3039–3043. doi: 10.1073/pnas.78.5.3039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Turner K. J., Plozza T. M., Holt P. G. Cell cycle-dependent fluctuations in IgE secretion in a human myeloma line. Clin Immunol Immunopathol. 1985 Aug;36(2):212–216. doi: 10.1016/0090-1229(85)90122-9. [DOI] [PubMed] [Google Scholar]
  41. Warnke R. A., Gatter K. C., Falini B., Hildreth P., Woolston R. E., Pulford K., Cordell J. L., Cohen B., De Wolf-Peeters C., Mason D. Y. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med. 1983 Nov 24;309(21):1275–1281. doi: 10.1056/NEJM198311243092102. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES